Single-cell pharmacogenomic landscapes of epigenetic therapy revealed by gastric cancer Perturb-seq
Gene expression signatures are widely used in cancer research. This study applies single-cell Perturb-seq to gastric cancer models under epigenetic therapies and reveals gene- and treatment-specific molecular phenotypes and drug-response pathways that have prognostic significance in primary tumours.